Source

AP-HP, Groupe hospitalier Henri-Mondor, Department of Hepatology, 94000 Créteil, France; Inserm U955, Créteil, France; Université Paris Est Creteil, Faculté de Médecine, Créteil, France.

Abstract

Liver transplantation for hepatocellular carcinoma is widely accepted as the best treatment for this cancer. Since transplantation has become widely available (mid-1980s), there has been no international consensus for this specific setting. This has now been done, and takes into account regional differences (cadaveric and living donor) and introduces expanded criteria, which vary according to the dynamics of the regional waiting list.